First Transfemoral Implantation of a Novel Transcatheter Valve in an LVAD Patient With Aortic Insufficiency.
AR, aortic regurgitation
CO, cardiac output
CTA, computed tomography angiography
LVAD, left ventricular assist device
LVEDD, left ventricular end diastolic dimension
NYHA, New York Heart Association
PA, pulmonary artery
PCWP, pulmonary capillary wedge pressure
RA, right atrial
RV, right ventricular
TAVR
TAVR, transcatheter aortic valve replacement
TEE, transesophageal echocardiogram
THV, transcatheter heart valve
TTE, transthoracic echocardiogram
aortic regurgitation
Journal
JACC. Case reports
ISSN: 2666-0849
Titre abrégé: JACC Case Rep
Pays: Netherlands
ID NLM: 101757292
Informations de publication
Date de publication:
01 Dec 2021
01 Dec 2021
Historique:
received:
08
06
2021
revised:
30
08
2021
accepted:
31
08
2021
entrez:
17
12
2021
pubmed:
18
12
2021
medline:
18
12
2021
Statut:
epublish
Résumé
An 80-year-old man with a destination left ventricular assist device (LVAD) presented with decompensated heart failure. Evaluation demonstrated numerous LVAD high power spike events, significant aortic regurgitation, and hemolysis. He underwent successful aortic valve replacement with a novel transcatheter valve and LVAD pump exchange that resulted in an improvement in his clinical status. (
Identifiants
pubmed: 34917959
doi: 10.1016/j.jaccas.2021.08.026
pii: S2666-0849(21)00841-X
pmc: PMC8642726
doi:
Types de publication
Case Reports
Langues
eng
Pagination
1806-1810Subventions
Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States
Informations de copyright
© 2021 The Authors.
Déclaration de conflit d'intérêts
Dr Khalique is part of a core laboratory contracting with JenaValve but has not received any direct compensation; has received consulting fees from Abbott Structural and Boston Scientific; and has received Speakers Bureau fees from Edwards Lifesciences. Dr George has received consulting fees from Cardiomech, Mitremedical, Atricure, Vdyne, Valcare Medical, DurVena, MITRx, and Johnson & Johnson. Dr Leon has reported institutional clinical research grants from Abbott, Boston Scientific, Edwards Lifesciences, Medtronic, and JenaValve. Dr Vahl has reported institutional funding to Columbia University Irving Medical Center from Boston Scientific, Edwards Lifesciences, JenaValve, Medtronic, and Siemens Healthineers; and has received consulting fees from Abbott Vascular, Boston Scientific, and Siemens Healthineers. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Références
JACC Cardiovasc Imaging. 2016 Jun;9(6):641-51
pubmed: 26684975
J Heart Lung Transplant. 2019 Sep;38(9):920-926
pubmed: 30898555
JACC Heart Fail. 2018 Nov;6(11):951-960
pubmed: 30384913
JACC Cardiovasc Interv. 2013 Jan;6(1):84-9
pubmed: 23347865
ASAIO J. 2014 Mar-Apr;60(2):183-8
pubmed: 24399060
ASAIO J. 2013 Jan-Feb;59(1):90-2
pubmed: 23271392
Circ Heart Fail. 2014 Mar 1;7(2):310-9
pubmed: 24415682
Artif Organs. 2021 Mar;45(3):297-302
pubmed: 33098153